Industry leading journal Genome Web has recently published an article on Syantra's fast path to commercialization in 2026.

Read it in detail here: https://www.genomeweb.com/cancer/syantra-nearing-commercialization-early-breast-cancer-test-large-scale-study

‍

NOTE: Genome Web login required

‍

Share this post

More from our archives

Announcements
December 9, 2025

Vincere Cancer Center Begins Recruitment for Clinical Studies of Pioneering Breast Cancer Screen for Women at High Risk

CALGARY, AB. - Today, Syantra, a liquid biopsy platform and innovation company that is changing the way cancer is detected, starting with Syantra DX™ Breast Cancer...
Read more
Announcements
November 3, 2025

Syantra and Alamo Breast Cancer Foundation launch first-of-its-kind partnership

CALGARY, AB. - Today, Syantra, a liquid biopsy platform and innovation company that is changing the way cancer is detected, starting with Syantra DX™ Breast Cancer...
Read more
Announcements
October 28, 2025

Syantra, Inc. Expands Reach and Impact to New Zealand through New Partnership with Breast Cancer Foundation NZ

CALGARY, AB. - Today, Syantra, a liquid biopsy platform and innovation company that is changing the way cancer is detected, starting with Syantra DX™ Breast Cancer...
Read more
View all